ACMR vs LRCX: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

LRCX is the larger of the two ($229.44B market cap): the incumbent the market prices for continued execution (14.97x forward earnings, beta 2.01). ACMR is the smaller challenger ($2.84B), priced similarly on forward earnings (13.77x): more room to run, but more to prove. ACMR is expected to grow revenue faster (29% vs 21% next year) at a similar price (13.77x vs 14.97x forward earnings). The case for LRCX rests on its own driver (AI-driven chip-capex supercycle): if you believe in that, LRCX fits; if you believe in what the numbers show today, ACMR does.

ACMR vs LRCX: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricACMRLRCXWhat it tells you
Market cap$2.84B$229.44BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E13.7714.97Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E25.3127.37Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta2.232.01Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range12% of range16% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book1.4916.50How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how ACMR and LRCX affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACMR and LRCX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACMR and LRCX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does ACM Research (ACMR) do?

ACM Research designs and sells production equipment for chip manufacturing, with a core in single-wafer wet cleaning tools that lift yield, plus a broadening lineup spanning electrochemical plating (ECP), stress-free polishing, furnace, PECVD and advanced wafer-level and panel-level packaging tools. Although the parent is US-headquartered and NASDAQ-listed, the large majority of revenue flows through its ACM Research (Shanghai) subsidiary serving Chinese fabs, where domestic equipment substitution policy has been a strong tailwind. The company has been diversifying its product mix and pushing beyond mainland China, including a first single-wafer cleaning delivery to a Singapore foundry, packaging-tool orders from North American and Southeast Asian customers, and a new 40,000-square-foot R&D and manufacturing site in Hillsboro, Oregon, opened in November 2026 as part of a plan to invest more than $100 million in its US operations.

Full ACMR guide

What does Lam Research (LRCX) do?

Lam Research is one of the largest semiconductor equipment makers in the world, specializing in wafer-fabrication tools used to build integrated circuits. It is a leader in two critical process steps: etch (precisely removing material to carve nanoscale features) and deposition (laying down ultra-thin films of material), along with related cleaning and surface-preparation systems. These steps are repeated hundreds of times to build modern 3D chip structures, and Lam's tools are essential to manufacturing advanced logic and especially memory chips (DRAM and NAND flash). Lam sells its systems to the world's leading chipmakers and foundries, then earns a large, recurring stream of revenue from spare parts, upgrades, and services for its big installed base of tools, which smooths the cyclical equipment-sales business. Demand is driven by capital spending from semiconductor manufacturers, which rises and falls with chip-industry cycles but trends structurally higher as AI, data centers, and advanced devices require more and more sophisticated chips. Headquartered in Fremont, California, Lam is a key enabler of leading-edge and memory chip production.

Full LRCX guide

ACMR vs LRCX: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • ACMR drivers: China domestic substitution; Product-line diversification.
  • LRCX drivers: AI-driven chip-capex supercycle; Leadership in etch and deposition.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The overwhelming risk is geopolitical: with most revenue tied to China, US export controls, entity-list actions or a broader trade rupture could sharply cut ACMR's addressable market. For LRCX, semiconductor equipment is highly cyclical, and Lam's new-tool sales swing sharply with chipmaker capital-spending cycles, especially in memory, which is among the most volatile end markets.

ACMR or LRCX: which should you pick?

If the story you believe is ACMR's (China domestic substitution), ACMR is the more direct way to own it; if it is LRCX's (AI-driven chip-capex supercycle), LRCX is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACMR and LRCX guides.

ACMR vs LRCX: the full fundamentals

ACMR. At ~$40.16 on November 20, 2026, ACMR trades near 25x trailing EPS of ~$1.60 and ~14x consensus 2027 EPS of ~$2.94, far below the ~67x trailing multiple it carried in June, because the share price fell ~50% over three months while forward estimates held. The company held about $1.32 billion of cash against ~$351 million of debt at September 30, 2026. The stock has been volatile, with a 52-week range of roughly $28 to $127, and the mean target of nine analysts was ~$103.56.

LRCX. At about $184 on November 20, 2026, Lam trades near 27 times trailing earnings and about 15 times analysts' fiscal 2028 EPS estimate of ~$12.27, a sharp compression from roughly 47x trailing in October even though earnings kept rising. The 30 analysts covering it have a mean target of about $362, nearly double the price, which shows how far the market's read on AI-driven memory and logic capex has moved away from the published estimates (fiscal 2027 revenue near $35.4 billion). The next report, estimated for late January 2027, carries consensus EPS of about $2.35 on ~$8.64 billion of revenue.

Headline figures (approximate, November 2026): ACMR shows revenue (ttm) ~$1.14B, q3 2026 revenue growth (yoy) ~36.6% (to ~$368M), q3 2026 adj. eps ~$0.55 (vs ~$0.52 est.; GAAP ~$0.02), 2026 revenue guidance (raised) ~$1.24B to $1.28B; LRCX shows revenue (ttm) ~$26.1 billion (September 2026 quarter ~$8.22B, +54% y/y), margins Gross ~51%, operating ~37%, net ~32% (Q1 FY2027 non-GAAP gross 52.4%), net income (ttm) ~$8.45 billion (EPS ~$6.71), p/e (trailing / forward) ~27x / ~15x.

The bottom line: ACMR vs LRCX

ACMR and LRCX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ACMR and LRCX exposure against your real portfolio. It is not an investment adviser.

Wondering how ACMR or LRCX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about ACM Research

Ask Walnut's AI anything about ACMR and see how it fits what you own.

FAQ

What is the difference between ACMR and LRCX?

+

ACM Research designs and sells production equipment for chip manufacturing, with a core in single-wafer wet cleaning tools that lift yield, plus a broadening lineup spanning electrochemical plating (ECP), stress-free polishing, furnace, PECVD and advanced wafer-level and panel-level packaging tools. Lam Research is one of the largest semiconductor equipment makers in the world, specializing in wafer-fabrication tools used to build integrated circuits. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ACMR or LRCX the better stock?

+

Neither is universally better. LRCX is the larger incumbent; ACMR is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ACMR or LRCX?

+

On forward P/E (as of November 2026), ACMR trades at 13.77x and LRCX at 14.97x, so ACMR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ACMR and LRCX?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ACMR vs LRCX?

+

ACMR: The overwhelming risk is geopolitical: with most revenue tied to China, US export controls, entity-list actions or a broader trade rupture could sharply cut ACMR's addressable market. Domestic competition is intensifying, with rival Kingsemi narrowing ACMR's single-wafer SPM lead and NAURA taking a stake in Kingsemi in March 2025 to consolidate China's wet-clean market. Chinese tools priced 20% to 30% below Western equipment are also beginning to pressure pricing and margins. Semiconductor equipment demand is cyclical, so a downturn in fab capital spending would hit shipments. The stock is also volatile: it fell ~50% in the three months to November 20, 2026 despite record results and a raised outlook, and free cash flow over the trailing year was about -$284 million as inventory and receivables grew with the order book. Margins are edging down (third-quarter non-GAAP gross margin of ~41.6% versus ~42.1% a year earlier), and GAAP earnings can swing on investment marks, as the ~$39 million unrealized loss in the third quarter showed. Even after the pullback the shares trade near 25x trailing earnings. LRCX: Semiconductor equipment is highly cyclical, and Lam's new-tool sales swing sharply with chipmaker capital-spending cycles, especially in memory, which is among the most volatile end markets. US export restrictions on advanced chipmaking equipment to China are a significant headwind, since China has been a large customer; tighter rules can cut a meaningful slice of revenue. Customer concentration among a handful of large chipmakers, intense competition from Applied Materials and Tokyo Electron, and sensitivity to memory pricing and macro demand all add risk. A downturn in chip capex or escalating trade restrictions would pressure results and the stock. China rose to 35% of revenue in the September 2026 quarter, so any tightening lands on a larger base, and management already expects that share to fall significantly in the December quarter. Valuation has been the other risk: at about 47 times trailing earnings in October the shares priced in a strong fiscal 2027, and the ~42% drop over the three months to November 20, 2026, during a quarter of record revenue, shows how quickly sentiment on AI capex can turn.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ACMR or LRCX; figures are approximate and dated (as of November 2026). Verify current data before investing.